Slide 1: Fact Sheet
FACT SHEET Stryker Corporation 2825 Airview Boulevard Kalamazoo, Michigan 49002 269 385 2600 INVESTOR CONTACT Katherine A. Owen Vice President, Strategy and Investor Relations katherine.owen@stryker.com 269 385 2600 MISSION: Charles DeCoster IV, MSA TOGETHER WITH OUR CUSTOMERS, Assoc. Manager, Inves
Slide 2: At a Glance
AT A GLANCE 100+ 2 2014 GEOGRAPHIC SALES countries where Stryker products ORGANIC REVENUE GROWTH1 are sold 5.8% International United 5.1% (Developed): States: 4.2% 35 24% 68% $9.7B 2.8% 2.6% 2.4% Emerging straight years of Markets: sales growth 8% 2012 2013 2014 Stryker MedTech Market 2 CAPITAL ALLO
Slide 3: Stryker Advantage
STRYKER ADVANTAGE 3 FOCUSED ON INNOVATION Stryker’s relentless focus on innovation remains a cornerstone of its success, driven by the Company’s enduring collaboration with LEADING PLAYER IN MEDTECH STRENGTH IN KEY HOSPITAL hospitals and healthcare providers, which Stryker is a broadly diversified m
Slide 4: Orthopaedics
ER OTH 4 S ORTHOPAEDICS IE IT KN EM EE TR S T R AU M A & E X SALES 43% OF TOTAL COMPANY SALES Financial and market information reflects 2014 results $4.2B OTHER RECONSTRUCTIVE HIPS ROBOTIC ARM Market Market Market ASSISTED PERFORMANCE H IPS TRAUMA Size Position Share SURGERY SOLUTIONS $5.9B #3 22% K
Slide 5: MedSurg
TY INS IL I S TR ABON UM 5 I LU I N MEDSURG T SOSTA EN TS SU INSTRUMENTS MEDICAL Market Size Market Position Market Share Market Size Market Position Market Share SALES 39% OF TOTAL COMPANY SALES M E D I CA L Financial and market information reflects 2014 results $3.5B #1 41% $5.6B #2 14% $3.8B Stry
Slide 6: Neurotechnology & Spine
IO - AN ACIAL CRILLOF A X 6 M NEUROTECHNOLOGY & SPINE N T ED I N ST R U W E R S SP ME N EU R O P O IN E SALES 18% OF TOTAL COMPANY SALES Financial and market information reflects 2014 results $1.7B NEURO POWERED INSTRUMENTS CRANIO- Market Market Market SPINE NE MAXILLOFACIAL UR VA Size Position Shar
Slide 7: M & A to Enhance Portfolio
M & A TO ENHANCE PORTFOLIO 7 CoAlign Patient Safety Ascent Porex Concentric Innovations, Inc. Technologies Pivot CHG Hospital OtisMed Orthovita Trauson Medical Beds 2009 2010 2011 2012 2013 2014 2015 Core Business Gaymar Memometal Surpass MAKO Small Bone Innovations Adjacency Sonopet Neurovascular B
Slide 8: Financial Summary
FINANCIAL SUMMARY 8 ($ IN MILLIONS, EXCEPT PER SHARE AMOUNTS) % OF SALES YR/YR CHANGE CONSOLIDATED OPERATIONS 2012 2013 2014 2012 2013 2014 2012 2013 2014 Net sales $8,657 $9,021 $9,675 100% 100% 100% 4.2% 4.2% 7.2% Cost of sales 2,781 2,977 3,291 32% 33% 34% (1.1%) 7.0% 10.5% Gross profit 5,876 6,0
Slide 9: Financial Summary
($ IN MILLIONS) 9 FINANCIAL CONDENSED BALANCE SHEETS 2012 2013 2014 Assets Cash and cash equivalents $1,395 $1,339 $1,795 SUMMARY Marketable securities 2,890 2,641 3,205 Accounts receivable (net) 1,430 1,518 1,572 Inventories 1,265 1,422 1,588 Other current assets 1,168 1,415 1,513 Total current ass
Slide 10: Executive Leadership Team and Additional Information
EXECUTIVE LEADERSHIP TEAM ADDITIONAL INFORMATION KEVIN A. LOBO M. KATHRYN FINK BIJOY S. N. SAGAR INDEPENDENT REGISTERED Chairman and Chief Executive Officer Vice President, Chief Human Resources Vice President, Chief Information Officer PUBLIC ACCOUNTING FIRM Officer, Global Human Resources Ernst &